| scholarly article | Q13442814 |
| P2093 | author name string | Jan Best | |
| Stefan Müller | |||
| Jens M Theysohn | |||
| Andreas Paul | |||
| Hideo A Baba | |||
| Jürgen Treckmann | |||
| Sonia Radunz | |||
| Tamás Benkö | |||
| P2860 | cites work | Management of hepatocellular carcinoma: An update | Q27860530 |
| New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada | Q27860904 | ||
| Yttrium-90 microspheres: radiation therapy for unresectable liver cancer | Q28204605 | ||
| Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma | Q28314897 | ||
| Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver | Q29616866 | ||
| Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis | Q29619508 | ||
| Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients | Q30892049 | ||
| Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes | Q35004090 | ||
| Resection and liver transplantation for hepatocellular carcinoma. | Q36140302 | ||
| Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations. | Q36573194 | ||
| Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators | Q37087879 | ||
| Chemoembolization and radioembolization for hepatocellular carcinoma. | Q37238192 | ||
| Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report | Q37952030 | ||
| Treatment for hepatocellular carcinoma with portal vein tumor thrombosis: the emerging role for radioembolization using yttrium-90. | Q38101443 | ||
| Yttrium-90 radioembolization as a bridge to liver transplantation: a single-institution experience | Q38155625 | ||
| Waitlist priority for hepatocellular carcinoma beyond milan criteria: a potentially appropriate decision without a structured approach | Q38168622 | ||
| In intermediate stage hepatocellular carcinoma: radioembolization with yttrium 90 or chemoembolization? | Q38984450 | ||
| How to decide about liver transplantation in patients with hepatocellular carcinoma: size and number of lesions or response to TACE? | Q39434937 | ||
| Yttrium-90 Radioembolization for Hepatocellular Carcinoma Prior to Liver Transplantation | Q40586816 | ||
| Long-term survival after recurrent hepatocellular carcinoma in liver transplant patients: clinical patterns and outcome variables | Q43254614 | ||
| Liver transplantation for hepatocellular cancer: UCL experience in 137 adult cirrhotic patients. Alpha-foetoprotein level and locoregional treatment as refined selection criteria. | Q45284698 | ||
| Use of yttrium-90 microsphere radioembolization of hepatocellular carcinoma as downstaging and bridge before liver transplantation: a case report. | Q46132216 | ||
| Hepatobiliary effects of 90yttrium microsphere therapy for unresectable hepatocellular carcinoma | Q47342397 | ||
| Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinoma | Q48058236 | ||
| Successful embolization of hepatocelluar carcinoma with yttrium-90 glass microspheres prior to liver transplantation. | Q51259014 | ||
| Use of yttrium-90 microspheres (TheraSphere) in a patient with unresectable hepatocellular carcinoma leading to liver transplantation: a case report. | Q51365628 | ||
| Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival. | Q51642133 | ||
| Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: A phase 2 study | Q57763422 | ||
| Epidemiology of Hepatocellular Carcinoma | Q58296509 | ||
| Radiologic-pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres | Q63198750 | ||
| Epidemiology of hepatocellular carcinoma | Q73541726 | ||
| Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma | Q79854314 | ||
| New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy | Q82877410 | ||
| Liver transplantation for hepatocellular carcinoma after yttrium therapy: a case report | Q83050753 | ||
| A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization | Q84121312 | ||
| Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma: oncologic marker of radiologic response, progression, and survival | Q84634948 | ||
| Alpha-fetoprotein response in advanced hepatocellular carcinoma receiving cytostatic agent | Q84911202 | ||
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 215-221 | |
| P577 | publication date | 2017-04-14 | |
| P1433 | published in | Annals of Transplantation | Q4767873 |
| P1476 | title | Long-Term Outcome After Liver Transplantation for Hepatocellular Carcinoma Following Yttrium-90 Radioembolization Bridging Treatment | |
| P478 | volume | 22 |
| Q56603210 | Trans-arterial radio-embolization: a new chance for patients with hepatocellular cancer to access liver transplantation, a world review | cites work | P2860 |
Search more.